SBC Medical Group Holdings (SBC) Investor presentation summary

Company overview and key figures

• Provides consulting and management services to medical corporations and clinics, operating the largest franchised clinic network in Japan and a leading position in the aesthetic medical industry.

• Operates 166 clinics in Japan and 2 overseas, with $193mn revenue, $82mn EBITDA, $39mn net income, and 32% ROE in FY2023.

• Achieved a 15% five-year CAGR in clinic numbers and a 71% customer repeat rate, serving 3.9 million annual customers.

Business model and services

• Operates a franchise model, providing consulting, management, marketing, procurement, and equipment leasing services to clinics.

• Franchise network covers diverse specialties: dermatology, aesthetic surgery, dentistry, hair removal, fertility, orthopedics, and more.

• Offers a fully digitized integrated system for clinic operations, enhancing efficiency and customer experience.

Market position and growth

• Holds a leading 31% market share among medium to large aesthetic clinic groups in Japan, with significant expansion after adding Rize and Gorilla Clinics.

• Five-year revenue CAGR of 24%, with revenue rising from $459mn in 2018 to $1.1bn in 2023 for franchisees.

• Market penetration remains low (10%), with growth potential targeting middle-aged women and men, and expansion into dermatology.